Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventing Complications of Insulin Resistance in Childhood and Adults
NCT00015626Phase 2Completed
- Sponsor
- National Center for Research Resources
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin, pioglitazone and rosiglitazone in insulin resistance (IR) and type 2 diabetes mellitus (T2DM), sponsored by National Center for Research Resources. Status: completed.
02
Drugs
metforminpioglitazonerosiglitazone
03
Conditions
insulin resistance (IR)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00015626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015626.